IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BERNARDI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.813
AS - Asia 5.597
EU - Europa 4.666
SA - Sud America 876
Continente sconosciuto - Info sul continente non disponibili 364
AF - Africa 135
OC - Oceania 19
Totale 21.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.537
SG - Singapore 2.172
CN - Cina 1.507
IT - Italia 1.326
BR - Brasile 700
PL - Polonia 659
DE - Germania 561
UA - Ucraina 519
HK - Hong Kong 507
VN - Vietnam 370
FI - Finlandia 348
BD - Bangladesh 319
FR - Francia 306
GB - Regno Unito 240
TR - Turchia 184
RU - Federazione Russa 181
IN - India 177
CA - Canada 142
IE - Irlanda 127
SE - Svezia 88
MX - Messico 64
JP - Giappone 62
AR - Argentina 60
IQ - Iraq 58
CZ - Repubblica Ceca 56
NL - Olanda 55
ES - Italia 49
ZA - Sudafrica 48
BE - Belgio 31
ID - Indonesia 30
CO - Colombia 27
EC - Ecuador 25
AT - Austria 23
VE - Venezuela 22
EG - Egitto 20
SA - Arabia Saudita 19
AU - Australia 18
MA - Marocco 17
UZ - Uzbekistan 17
TH - Thailandia 16
JM - Giamaica 15
DK - Danimarca 14
JO - Giordania 14
MY - Malesia 14
IR - Iran 13
PK - Pakistan 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
LT - Lituania 12
PY - Paraguay 11
CR - Costa Rica 10
GR - Grecia 10
BO - Bolivia 9
KR - Corea 9
LK - Sri Lanka 9
NG - Nigeria 9
PE - Perù 9
AZ - Azerbaigian 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
ET - Etiopia 8
KE - Kenya 8
NP - Nepal 8
PT - Portogallo 8
CL - Cile 7
KG - Kirghizistan 7
PA - Panama 7
PH - Filippine 7
OM - Oman 6
RO - Romania 6
HN - Honduras 5
KZ - Kazakistan 5
LB - Libano 5
PS - Palestinian Territory 5
TN - Tunisia 5
UY - Uruguay 5
BG - Bulgaria 4
HR - Croazia 4
LV - Lettonia 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AL - Albania 3
CU - Cuba 3
EU - Europa 3
GT - Guatemala 3
HU - Ungheria 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MT - Malta 2
MU - Mauritius 2
Totale 21.083
Salva come PNG Salva come JPEG
Città #
Singapore 1.193
Ashburn 1.052
San Jose 785
Fairfield 711
Warsaw 643
Hong Kong 504
Woodbridge 457
New York 377
Chandler 372
Beijing 370
Jacksonville 354
Houston 320
Seattle 303
Wilmington 274
Ann Arbor 270
Cambridge 264
Brescia 262
The Dalles 251
Council Bluffs 241
Los Angeles 233
Helsinki 223
Dallas 219
Princeton 219
Munich 191
Lauterbourg 153
Des Moines 127
Istanbul 126
Dublin 124
Ho Chi Minh City 122
Milan 120
Shanghai 111
Santa Clara 104
Columbus 84
San Francisco 84
São Paulo 83
Buffalo 78
Hanoi 73
Boardman 72
Nanjing 72
Turku 70
Chicago 65
Redondo Beach 65
Rome 64
Orem 61
Moscow 60
Brooklyn 55
San Diego 48
Tokyo 47
Dearborn 46
London 43
Brno 41
Nanchang 40
Tianjin 40
Toronto 40
Frankfurt am Main 39
Changsha 37
Pune 37
Denver 34
Nuremberg 33
Phoenix 33
Atlanta 32
Chennai 32
Jinan 32
Montreal 31
Brussels 30
Johannesburg 30
Shenyang 28
Mexico City 25
Guangzhou 24
Turin 24
Baghdad 23
Charlotte 23
Stockholm 23
Poplar 22
Boston 21
Genoa 21
Lappeenranta 21
Manchester 21
Romola 21
Amsterdam 20
Rio de Janeiro 20
Verona 20
Bologna 19
Jiaxing 19
Ningbo 19
Belo Horizonte 18
Dong Ket 18
Paris 18
Da Nang 17
Hangzhou 17
Brasília 16
Hebei 16
Düsseldorf 15
Newark 15
Tashkent 15
Amman 14
Jakarta 14
Zhengzhou 14
Ankara 13
Curitiba 13
Totale 13.453
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 331
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 298
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 293
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 272
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 259
Zebrafish disease models in hematology: Highlights on biological and translational impact 241
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 217
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 216
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 213
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 212
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 202
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 193
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 189
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 189
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 187
Alterations of AQP2 expression in trigeminal ganglia in a murine inflammation model 184
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 183
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 182
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 180
Advances in CMV Management: A Single Center Real-Life Experience 179
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 175
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 173
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 170
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 170
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 169
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 167
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 167
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 167
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 166
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 162
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 162
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 161
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 161
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 158
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 157
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 156
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 156
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 155
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 155
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 155
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 151
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 151
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 150
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 148
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 147
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 145
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 144
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 144
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 143
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 142
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 140
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 139
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 139
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 136
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 136
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 135
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 134
ACHIEVEMENT OF COMPLETE REMISSION WITH PONATINIB THERAPY FOR PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A CASE REPORT. 134
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 134
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 134
Abstract A27: European Network NGS-PTL preliminary data: Whole exome sequencing identifies mutations of ALDH2, RETSAT, HSPG2, CHPF and other metabolic genes as a novel functional category in acute myeloid leukemia 134
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 132
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 132
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 132
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 132
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 131
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 131
3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients 130
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation 130
Genomic Analysis Of Notch Mutations In a Case Of Alagille Syndrome With Acute Lymphoblastic Leukemia 129
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 128
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 127
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 127
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 126
Mineralization of 3D Osteogenic Model Based on Gelatin-Dextran Hybrid Hydrogel Scaffold Bioengineered with Mesenchymal Stromal Cells: A Multiparametric Evaluation 126
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 125
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) 125
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a CML Campus Study 124
PYROSEQUENCING IS A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY. 124
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 124
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 123
AZACITIDINE (AZA) FOR RELAPSED HIGH RISK MYELODYSPLASIC SYNDROME AFTER INTRABONE CORD BLOOD TRANSPLANTATION: A CASE REPORT. 122
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 122
PROGNOSTIC RELEVANCE OF WT1 MOLECULAR LEVELS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. 121
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 120
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 120
THE PYROSEQUENCING: A NEW PROMISING APPROACH TO PERFORM HLA TYPING AND SELECT THE STEM CELL DONOR IN A QUICKLY, SIMPLE AND ACCURATE WAY 119
EARLY EXTRACORPOREAL PHOTOAPHERESIS FOR THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE (AGVHD). 119
EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO) 118
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 118
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 117
COMBINED EFFECTS OF MESENCHYMAL STROMAL CELLS (MSC) AND STIMULATORY CYTOKINES ON THE ex vivo GROWTH OF UMBILICAL CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS (UCB-HPC) 117
Secondary Myeloid Neoplasms after CD19 CAR-T Cell Therapy: Real-Life Multicenter Data from the Clonhema Study 115
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? 115
Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome 115
Detection of newly produced T and B lymphocytes by digital PCR in blood stored dry on nylon flocked swabs 115
Extracellular Vesicles: From Biomarkers to Therapeutic Tools 115
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 113
MULTI-GENOTYPE OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) TO STUDY GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECTS IN ALLOGENEIC STEM CELL TRANSPLANTATION. 112
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 111
Totale 15.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022870 0 0 44 63 39 75 52 73 63 143 75 243
2022/20231.112 154 48 45 84 113 229 8 121 165 16 64 65
2023/20241.539 71 32 121 86 92 368 85 77 260 26 41 280
2024/20253.578 61 77 50 390 291 279 236 167 561 277 675 514
2025/20268.140 666 796 497 980 860 651 1.243 372 570 764 412 329
2026/2027860 330 354 176 0 0 0 0 0 0 0 0 0
Totale 21.470